|
🐜
|
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors
39 auth.
Xiangdong Lv,
Xuan Lu,
Jin Cao,
Qin Luo,
Yao Ding,
Fanglue Peng,
A. Pataer,
Dong Lu,
Dong Han,
Eric Malmberg,
Doug W. Chan,
Xiaoran Wang,
Sara R. Savage,
Sufeng Mao,
Jingjing Yu,
...
Fei Peng,
Liang Yan,
Huan Meng,
L. Maneix,
Yumin Han,
Yiwen Chen,
W. Yao,
Eric Chang,
A. Catic,
Xia Lin,
G. Miles,
Pengxiang Huang,
Zheng Sun,
Bryan Burt,
Huamin Wang,
Jin Wang,
Q. Yao,
Bing Zhang,
J. Roth,
Bert W. O’Malley,
M. Ellis,
M. Rimawi,
H. Ying,
Xi Chen
|
5 |
2023 |
5
🐜
|
|
🐜
|
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors.
12 auth.
Gabriel Espinosa-Carrasco,
Edison Chiu,
Aurora Scrivo,
P. Zumbo,
Asim Dave,
D. Betel,
...
Sung Wook Kang,
Hee-Jin Jang,
M. Hellmann,
Bryan Burt,
Hyun-Sung Lee,
A. Schietinger
|
5 |
2024 |
5
🐜
|
|
🐜
|
Clonal gene signatures predict prognosis in mesothelioma and lung adenocarcinoma
10 auth.
Yupei Lin,
Bryan Burt,
Hyun-Sung Lee,
Thinh T. Nguyen,
Hee-Jin Jang,
Claire Lee,
...
Wei Hong,
R. Ripley,
C. Amos,
Chao Cheng
|
1 |
2024 |
1
🐜
|
|
🐜
|
Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing.
18 auth.
P. Shafer,
W. Leung,
Mae L Woods,
Jong Min Choi,
Carlos M. Rodriguez-Plata,
Arushana Maknojia,
Andres Mosquera,
Lauren K. Somes,
Jarrett Joubert,
Anthony Manliguez,
...
Rashi Ranjan,
Bryan Burt,
Hyun-Sung Lee,
Bing Zhang,
S. Fuqua,
Cliona Rooney,
A. Leen,
V. Hoyos
|
0 |
2024 |
0
🐜
|
